219
Views
9
CrossRef citations to date
0
Altmetric
ORIGINAL INVESTIGATIONS

Wide impairment of cerebral serotoninergic activity but inter-individual heterogeneity in bulimia nervosa patients: a pilot [18F]MPPF/PET study

, , , , &
Pages 599-608 | Received 28 Nov 2013, Accepted 11 Jun 2014, Published online: 23 Jul 2014

References

  • American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association.
  • Andreason PJ, Altemus M, Zametkin AJ, King AC, Lucinio J, Cohen RM. 1992. Regional cerebral glucose metabolism in bulimia nervosa. Am J Psychiatry 149:1506–1513.
  • Bailer UF, Bloss CS, Frank GK, Price JC, Meltzer CC, Mathis CA, et al. 2011. 5-HT(1)A receptor binding is increased after recovery from bulimia nervosa compared to control women and is associated with behavioral inhibition in both groups. Int J Eat Disord 44:477–487.
  • Bailer UF, Frank GK, Henry SE, Price JC, Meltzer CC, Becker C, et al. 2007a. Serotonin transporter binding after recovery from eating disorders. Psychopharmacology (Berlin) 195:315–324.
  • Bailer UF, Frank GK, Henry SE, Price JC, Meltzer CC, Mathis CA, et al. 2007b. Exaggerated 5-HT1A but normal 5-HT2A receptor activity in individuals ill with anorexia nervosa. Biol Psychiatry 61:1090–1099.
  • Bailer UF, Frank GK, Henry SE, Price JC, Meltzer CC, Weissfeld L, et al. 2005. Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635. Arch Gen Psychiatry 62:1032–1041.
  • Bailer UF, Frank GK, Price JC, Meltzer CC, Becker C, Mathis CA, et al. 2013. Interaction between serotonin transporter and dopamine D2/D3 receptor radioligand measures is associated with harm avoidant symptoms in anorexia and bulimia nervosa. Psychiatry Res 211:160–168.
  • Bencherif B, Guarda AS, Colantuoni C, Ravert HT, Dannals RF, Frost JJ. 2005. Regional mu-opioid receptor binding in insular cortex is decreased in bulimia nervosa and correlates inversely with fasting behavior. J Nucl Med 46:1349–1351.
  • Blanke O, Mohr C, Michel CM, Pascual-Leone A, Brugger P, Seeck M, et al. 2005. Linking out-of-body experience and self processing to mental own-body imagery at the temporoparietal junction. J Neurosci 25:550–557.
  • Brooks SJ, O’Daly OG, Uher R, Friederich HC, Giampietro V, Brammer M, et al. 2011. Differential neural responses to food images in women with bulimia versus anorexia nervosa. PLoS One 6:e22259.
  • Cooper Z, Fairburn CG. 1987. The Eating Disorders Examination: a semistructured interview for the assessment of the specific psychopathology of eating disorders. Int J Eat Disord 6:1–8.
  • Costes N, Merlet I, Ostrowsky K, Faillenot I, Lavenne F, Zimmer L, et al. 2005. A 18F-MPPF PET normative database of 5-HT1A receptor binding in men and women over aging. J Nucl Med 46:1980–1989.
  • Costes N, Merlet I, Zimmer L, Lavenne F, Cinotti L, Delforge J, et al. 2002. Modeling [18 F]MPPF positron emission tomography kinetics for the determination of 5-hydroxytryptamine(1A) receptor concentration with multiinjection. J Cereb Blood Flow Metab 22:753–765.
  • Delvenne V, Goldman S, De Maertelaer V, Lotstra F. 1999. Brain glucose metabolism in eating disorders assessed by positron emission tomography. Int J Eat Disord 25:29–37.
  • Derogatis LR. 1983 Clinical Psychometric Research, Towson, MD, USA.
  • Downing PE, Jiang Y, Shuman M, Kanwisher N. 2001. A cortical area selective for visual processing of the human body. Science 293:2470–2473.
  • Estour B, Germain N, Diconne E, Frere D, Cottet-Emard JM, Carrot G, et al. 2010. Hormonal profile heterogeneity and short-term physical risk in restrictive anorexia nervosa. J Clin Endocrinol Metab 95:2203–2210.
  • Faris PL, Kim SW, Meller WH, Goodale RL, Oakman SA, Hofbauer RD, et al. 2000. Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: a randomised, double-blind trial. Lancet 355: 792–797.
  • Galusca B, Costes N, Zito NG, Peyron R, Bossu C, Lang F, et al. 2008. Organic background of restrictive-type anorexia nervosa suggested by increased serotonin 1A receptor binding in right frontotemporal cortex of both lean and recovered patients: [18F]MPPF PET scan study. Biol Psychiatry 64:1009–1013.
  • Garavan H, Pankiewicz J, Bloom A, Cho JK, Sperry L, Ross TJ, et al. 2000. Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. Am J Psychiatry 157:1789–1798.
  • Garner DM, Olmstead MP, Polivy J. 1983. Development and validation of a multidimensional eating disorder inventory for anorexia nervosa and bulimia. Int J Eat Disord 2:15–34.
  • Gerard N, Pieters G, Goffin K, Bormans G, Van Laere K. 2011. Brain type 1 cannabinoid receptor availability in patients with anorexia and bulimia nervosa. Biol Psychiatry 70:777–784.
  • Ginovart N, Hassoun W, Le Bars D, Weissmann D, Leviel V. 2000. In vivo characterization of p-[(18)F]MPPF, a fluoro analog of WAY-100635 for visualization of 5-HT(1a) receptors. Synapse 35:192–200.
  • Goethals I, Vervaet M, Audenaert K, Van de Wiele C, Ham H, Vandecapelle M, et al. 2004. Comparison of cortical 5-HT2A receptor binding in bulimia nervosa patients and healthy volunteers. Am J Psychiatry 161:1916.
  • Goldman-Rakic PS, Selemon LD, Schwartz ML. 1984. Dual pathways connecting the dorsolateral prefrontal cortex with the hippocampal formation and parahippocampal cortex in the rhesus monkey. Neuroscience 12:719–743.
  • Hume S, Hirani E, Opacka-Juffry J, Myers R, Townsend C, Pike V, et al. 2001. Effect of 5-HT on binding of [(11)C] WAY 100635 to 5-HT(IA) receptors in rat brain, assessed using in vivo microdialysis nd PET after fenfluramine. Synapse 41:150–159.
  • Jimerson DC, Lesem MD, Kaye WH, Brewerton TD. 1992. Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid from bulimic patients with frequent binge episodes. Arch Gen Psychiatry 49:132–138.
  • Kabani N, MacDonald DJ, Holmes CJ, Evans AC. 1998. 3D anatomical atlas of the human brain. Neuroimage 7(Suppl 4, Pt 2):S717.
  • Kaye W, Gendall K, Strober M. 1998. Serotonin neuronal function and selective serotonin reuptake inhibitor treatment in anorexia and bulimia nervosa. Biol Psychiatry 44:825–838.
  • Kaye WH, Frank GK, Bailer UF, Henry SE, Meltzer CC, Price JC, et al. 2005. Serotonin alterations in anorexia and bulimia nervosa: new insights from imaging studies. Physiol Behav 85:73–81.
  • Kaye WH, Frank GK, Meltzer CC, Price JC, McConaha CW, Crossan PJ, et al. 2001. Altered serotonin 2A receptor activity in women who have recovered from bulimia nervosa. Am J Psychiatry 158:1152.
  • Kaye WH, Gendall KA, Fernstrom MH, Fernstrom JD, McConaha CW, Weltzin TE. 2000. Effects of acute tryptophan depletion on mood in bulimia nervosa. Biol Psychiatry 47:151–157.
  • Levitan RD, Kaplan AS, Joffe RT, Levitt AJ, Brown GM. 1997. Hormonal and subjective responses to intravenous meta- chlorophenylpiperazine in bulimia nervosa. Arch Gen Psychiatry 54:521–527.
  • Marazziti D, Macchi E, Rotondo A, Placidi GF, Cassano GB. 1988. Involvement of serotonin system in bulimia. Life Sci 43:2123–2126.
  • Marsh R, Horga G, Wang Z, Wang P, Klahr KW, Berner LA, et al. 2011. An FMRI study of self-regulatory control and conflict resolution in adolescents with bulimia nervosa. Am J Psychiatry 168:1210–1220.
  • Marsh R, Steinglass JE, Gerber AJ, Graziano O’Leary K, Wang Z, Murphy D, et al. 2009. Deficient activity in the neural systems that mediate self-regulatory control in bulimia nervosa. Arch Gen Psychiatry 66:51–63.
  • Merlet I, Ryvlin P, Costes N, Dufournel D, Isnard J, Faillenot I, et al. 2004. Statistical parametric mapping of 5-HT1A receptor binding in temporal lobe epilepsy with hippocampal ictal onset on intracranial EEG. Neuroimage 22:886–896.
  • Mohr HM, Roder C, Zimmermann J, Hummel D, Negele A, Grabhorn R. 2011. Body image distortions in bulimia nervosa: investigating body size overestimation and body size satisfaction by fMRI. Neuroimage 56:1822–1831.
  • Naqvi NH, Rudrauf D, Damasio H, Bechara A. 2007. Damage to the insula disrupts addiction to cigarette smoking. Science 315:531–534.
  • Nozoe S, Naruo T, Yonekura R, Nakabeppu Y, Soejima Y, Nagai N, et al. 1995. Comparison of regional cerebral blood flow in patients with eating disorders. Brain Res Bull 36: 251–255.
  • Phillips ML, Drevets WC, Rauch SL, Lane R. 2003. Neurobiology of emotion perception I: The neural basis of normal emotion perception. Biol Psychiatry 54:504–514.
  • Pichika R, Buchsbaum MS, Bailer U, Hoh C, Decastro A, Buchsbaum BR, et al. 2012. Serotonin transporter binding after recovery from bulimia nervosa. Int J Eat Disord 45: 345–352.
  • Ro O, Martinsen EW, Hoffart A, Rosenvinge JH. 2003. Short-term follow-up of severe bulimia nervosa after inpatient treatment. Eur Eat Disord Rev 11:405–417.
  • Scherag S, Hebebrand J, Hinney A. 2010. Eating disorders: the current status of molecular genetic research. Eur Child Adolesc Psychiatry:1–16.
  • Schienle A, Schäfer A, Hermann A, Vaitl D. 2009. Binge-eating disorder: reward sensitivity and brain activation to images of food. Biol Psychiatry 65:654–661.
  • Shapiro JR, Berkman ND, Brownley KA, Sedway JA, Lohr KN, Bulik CM. 2007. Bulimia nervosa treatment: a systematic review of randomized controlled trials. Int J Eat Disord 40: 321–336.
  • Sibon I, Benkelfat C, Gravel P, Aznavour N, Costes N, Mzengeza S, et al. 2008. Decreased [18F]MPPF binding potential in the dorsal raphe nucleus after a single oral dose of fluoxetine: a positron-emission tomography study in healthy volunteers. Biol Psychiatry 63:1135–1140.
  • Smith KA, Fairburn CG, Cowen PJ. 1999. Symptomatic relapse in bulimia nervosa following acute tryptophan depletion. Arch Gen Psychiatry 56:171–176.
  • Steiger H. 2004. Eating disorders and the serotonin connection: state, trait and developmental effects. J Psychiatry Neurosci 29:20–29.
  • Stephan E, Pardo JV, Faris PL, Hartman BK, Kim SW, Ivanov EH, et al. 2003. Functional neuroimaging of gastric distention. J Gastrointest Surg 7:740–749.
  • Tataranni PA, Gautier JF, Chen K, Uecker A, Bandy D, Salbe AD, et al. 1999. Neuroanatomical correlates of hunger and satiation in humans using positron emission tomography. Proc Natl Acad Sci USA 96:4569–4574.
  • Tauscher J, Pirker W, Willeit M, de Zwaan M, Bailer U, Neumeister A, et al. 2001. [123I]beta-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa. Biol Psychiatry 49:326–332.
  • Tiihonen J, Keski-Rahkonen A, Lopponen M, Muhonen M, Kajander J, Allonen T, et al. 2004. Brain serotonin 1A receptor binding in bulimia nervosa. Biol Psychiatry 55:871–873.
  • Uher R, Yoganathan D, Mogg A, Eranti SV, Treasure J, Campbell IC, et al. 2005. Effect of left prefrontal repetitive transcranial magnetic stimulation on food craving. Biol Psychiatry 58:840–842.
  • Van den Eynde F, Claudino AM, Mogg A, Horrell L, Stahl D, Ribeiro W, et al. 2010. Repetitive transcranial magnetic stimulation reduces cue-induced food craving in bulimic disorders. Biol Psychiatry 67:793–795.
  • Van Strien T, Friejters JE, Bergers GPA, Defares PB. 1986. The Dutch Eating Behavior Questionnaire for assessment os restrained, emotional and external eating behavior. Int J Eat Disord 5:295–315.
  • Zimmer L, Mauger G, Le Bars D, Bonmarchand G, Luxen A, Pujol JF. 2002. Effect of endogenous serotonin on the binding of the 5-hT1A PET ligand 18F-MPPF in the rat hippocampus: kinetic beta measurements combined with microdialysis. J Neurochem 80:278–286.
  • Zimmer L, Rbah L, Giacomelli F, Le Bars D, Renaud B. 2003. A reduced extracellular serotonin level increases the 5-HT1A PET ligand 18F-MPPF binding in the rat hippocampus. J Nucl Med 44:1495–1501.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.